Actively Recruiting
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
Led by Beijing Anzhen Hospital · Updated on 2026-05-14
1400
Participants Needed
3
Research Sites
50 weeks
Total Duration
On this page
Sponsors
B
Beijing Anzhen Hospital
Lead Sponsor
B
Beijing Chao Yang Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to employ a cluster randomized controlled trial to evaluate the effectiveness of an mHealth-Based Multi-faceted Cardiovascular Health Intervention Model among Overweight/Obese Individuals with Cardiometabolic Preconditions, thereby providing theoretical foundations and practical guidance for the prevention and management of this population.
CONDITIONS
Official Title
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older, no gender restriction
- Overweight or obesity defined as BMI 24.0-32.4 kg/m² or waist circumference ≥90 cm for males and ≥85 cm for females
- Having at least one metabolic high-risk condition: prehypertension, prediabetes, or borderline elevated blood lipids without diagnosis or recent medication for hypertension, diabetes, or dyslipidemia
- Local permanent resident planning to stay in the area for at least 12 months after enrollment
- Basic reading, writing, and comprehension skills
- Proficient in using internet-connected smartphones and able to complete basic app operations independently
- Provided written informed consent
You will not qualify if you...
- Secondary obesity diagnosed by a doctor at secondary or higher-level medical institutions
- Cardiovascular or cerebrovascular diseases including myocardial infarction, stroke, heart failure, arrhythmia, or history of coronary intervention or cardiac surgery, or high 10-year cardiovascular disease risk
- Serious diseases affecting survival such as malignant tumors, AIDS, liver or kidney failure
- Pregnancy, lactation, or risk of becoming pregnant within one year
- Severe neuropsychiatric diseases causing cognitive or communication impairment, such as dementia, Alzheimer's disease, Parkinson's syndrome
- Limited daily mobility
- Undergoing or planning weight loss surgery, medication, or other methods
- Currently participating in other lifestyle intervention trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Beijing Chao Yang Hospital
Beijing, Beijing Municipality, China, 100013
Actively Recruiting
2
Cangzhou Central Hospital
Cangzhou, Hebei, China, 061012
Actively Recruiting
3
Health Community Group of Yuhuan People's Hosptial
Yuhuan, Zhejiang, China, 317608
Actively Recruiting
Research Team
W
wei wang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here